(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.34%) $79.26
(5.62%) $2.31
(0.78%) $2 340.30
(2.77%) $28.37
(0.85%) $993.00
(-0.28%) $0.928
(-0.23%) $10.87
(-0.20%) $0.799
(0.88%) $92.54
Quarter results today
(bmo 2024-05-09)
Expected move: +/- 10.93%
-0.51% $ 0.177
Live Chart Being Loaded With Signals
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 322 228 |
Średni wolumen | 2.11M |
Kapitalizacja rynkowa | 9.63M |
EPS | $0 ( 2024-03-25 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.130 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-19 | Schneid Yair | Buy | 99 371 | Common Stock |
2024-04-19 | Schneid Yair | Buy | 215 | Common Stock |
2024-04-19 | Schneid Yair | Buy | 314 | Common Stock |
2024-04-19 | Schneid Yair | Buy | 100 | Common Stock |
2024-04-18 | Schneid Yair | Buy | 74 202 | Common Stock |
INSIDER POWER |
---|
99.83 |
Last 95 transactions |
Buy: 7 344 028 | Sell: 846 527 |
Wolumen Korelacja
Galera Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
LIAN | 0.848 |
IMAB | 0.843 |
MEUSW | 0.842 |
PXLW | 0.841 |
ADXN | 0.839 |
LEGO | 0.833 |
FORA | 0.828 |
VYGR | 0.814 |
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Galera Therapeutics Inc Korelacja - Waluta/Towar
Galera Therapeutics Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-259 000 (0.00 %) |
EPS: | $-1.330 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-259 000 (0.00 %) |
EPS: | $-1.330 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-114 000 (0.00 %) |
EPS: | $-2.30 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.06 |
Financial Reports:
No articles found.
Galera Therapeutics Inc
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej